In an early cross-sectional study, serum myostatin levels measured by radioimmunoassay (RIA) were reported to be significantly elevated with advancing age and declining lean mass, suggesting that myostatin may serve as a biomarker of sarcopenia in women and men [14]. Here, MSTN is linked to sarcopenia.